Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
American Journal of Obstetrics and Gynecology|March 15, 1983
Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerH W Bruckner, C J Cohen, J D Goldberg, et al.
Gene Therapy|May 23, 2008
Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognitionS Yang, C J Cohen, P D Peng, et al.
Clinical and Experimental Rheumatology|January 26, 2012
Evidence of genetic association between TNFRSF1A encoding the p55 tumour necrosis factor receptor, and ankylosing spondylitis in UK CaucasiansT Karaderi, J J Pointon, T W H Wordsworth, et al.
The New England Journal of Medicine|March 15, 2001
The cost effectiveness of combination antiretroviral therapy for HIV diseaseK A Freedberg, E Losina, M C Weinstein, et al.
Biochemistry|August 25, 1999
WIN 17317-3, a new high-affinity probe for voltage-gated sodium channelsS G Wanner, H Glossmann, H G Knaus, et al.
The Journal of General Physiology|August 1, 1997
Functional expression of Drosophila para sodium channels. Modulation by the membrane protein TipE and toxin pharmacologyJ W Warmke, R A Reenan, P Wang, et al.
HIV Clinical Trials|July 10, 2013
Rilpivirine versus efavirenz in HIV-1-infected subjects receiving emtricitabine/tenofovir DF: pooled 96-week data from ECHO and THRIVE StudiesM R Nelson, R A Elion, C J Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectinN S Kane, B Hirschberg, S Qian, et al.
Recent Progress in Hormone Research|January 1, 1996
Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary glandR G Smith, S S Pong, G Hickey, et al.
The Journal of Infectious Diseases|February 11, 2000
A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. American Foundation for AIDS Research Community-Based Clinical Trials NetworkJ A Hellinger, M K Iwane, J J Smith, et al.
Pageof 18